{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T22:27:28Z","timestamp":1770157648682,"version":"3.49.0"},"reference-count":163,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Diabetes is a chronic inflammatory disease due to decreased insulin release or insulin resistance. Diabetes complications stem from high blood sugar damaging blood vessels and nerves, leading to issues like heart disease, stroke, kidney failure, nerve damage, vision loss, foot ulcers, gum disease, skin infections, and digestive\/bladder issues. Galectins, especially galectin-3, are emerging as key players in diabetes complications, promoting fibrosis, inflammation, and vascular damage. This suggests that galectins may be potential therapeutic targets in diabetes and its complications, and a need to understand their role and therapeutic potential. The objective of this review is to synthesize current evidence on galectin biology in diabetes mellitus (mainly on type II diabetes) and DFUs, delineate their mechanistic roles in metabolic dysfunction and wound healing, summarize findings from human and preclinical studies, and evaluate emerging diagnostic and therapeutic strategies. Finally, this review highlights key gaps that must be addressed to advance clinical translation. The literature search suggests that galectins play a critical role in the pathogenesis of diabetes and related complications and may be potential therapeutic targets.<\/jats:p>","DOI":"10.3390\/biom16020232","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:00:58Z","timestamp":1770109258000},"page":"232","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectins: Role and Therapeutics in Diabetes and Diabetic Foot Ulcers"],"prefix":"10.3390","volume":"16","author":[{"given":"Alhasan","family":"Alobaidi","sequence":"first","affiliation":[{"name":"Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan Al","family":"Judeid","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Citrus College, Glendora, CA 91741, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6286-2341","authenticated-orcid":false,"given":"Vikrant","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e70044","DOI":"10.1111\/1753-0407.70044","article-title":"Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients with Type 2 Diabetes Mellitus Complicated with Cardiovascular Disease: A Network Meta-Analysis","volume":"17","author":"Shi","year":"2025","journal-title":"J. Diabetes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.12701\/jyms.2023.00682","article-title":"Management of diabetic foot ulcers: A narrative review","volume":"40","author":"Kim","year":"2023","journal-title":"J. Yeungnam Med. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13098-025-01822-5","article-title":"New technologies applied in self-care to patients with diabetic foot ulcers: A scoping review","volume":"17","author":"Mendez","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41420-025-02808-y","article-title":"Research progress on the role and mechanisms of ferroptosis in diabetic wound repair","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mohammadi, A., Goharimehr, M., Darvishi, A., Heshmat, R., Esfahani, E.N., Shafiee, G., Ostovar, A., and Daroudi, R. (2025). Economic burden of Type 2 diabetes in Iran in 2022. BMC Public Health, 25.","DOI":"10.1186\/s12889-024-21247-5"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e70406","DOI":"10.1002\/mco2.70406","article-title":"Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities","volume":"6","author":"Wang","year":"2025","journal-title":"MedComm (2020)"},{"key":"ref_7","first-page":"82","article-title":"Pathogenesis, evaluation, and recent management of diabetic foot ulcer","volume":"51","author":"Wijaya","year":"2019","journal-title":"J. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Afonso, A.C., Oliveira, D., Saavedra, M.J., Borges, A., and Simoes, M. (2021). Biofilms in Diabetic Foot Ulcers: Impact, Risk Factors and Control Strategies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158278"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ray, H., Weis, C., Nwaeze, C., Zhou, V., Basu, P., and Mitra, A. (2025). Development and Control of Biofilms in Diabetic Foot Infections: A Narrative Review. Acta Microbiol. Hell., 70.","DOI":"10.3390\/amh70010009"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105400","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chaudhary, S., Chaudhary, S., Rawat, S., Kulkarni, A., Bilgrami, A.L., Perveen, A., Alghamdi, B.S., Zughaibi, T.A., Ashraf, G.M., and Alam, M.Z. (2022). Galectins-Potential Therapeutic Targets for Neurodegenerative Disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911012"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Marino","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11154-021-09704-7","article-title":"Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot","volume":"23","author":"Li","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease","volume":"35","author":"Lee","year":"2021","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12933-022-01690-7","article-title":"The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease","volume":"21","author":"Mansour","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yu, X., Qian, J., Ding, L., Yin, S., Zhou, L., and Zheng, S. (2023). Galectin-1: A Traditionally Immunosuppressive Protein Displays Context-Dependent Capacities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076501"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4103\/ijem.ijem_270_22","article-title":"Galectin-3 as a Potential Biomarker of Microvascular Complications in Patients with Type 2 Diabetes","volume":"26","author":"Kumar","year":"2022","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhu, N., Zhu, L., Huang, B., Xiang, W., and Zhao, X. (2022). Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.868372"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1038\/s41467-025-62320-w","article-title":"Galectin-3-integrin alpha5beta1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, T., Zhang, Y., Guo, Y., Zhao, M., Cai, X., and Feng, S. (2025). Galectins-1, -3 and -9 in leukemia: Mechanistic insights and therapeutic translation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1685266"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hermenean, A., Oatis, D., Herman, H., Ciceu, A., D\u2019Amico, G., and Trotta, M.C. (2022). Galectin 1-A Key Player between Tissue Repair and Fibrosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105548"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sewgobind, N.V., Albers, S., and Pieters, R.J. (2021). Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology. Biomolecules, 11.","DOI":"10.3390\/biom11111720"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108082","DOI":"10.1016\/j.diabres.2020.108082","article-title":"Potential biomarkers for early detection of diabetic kidney disease","volume":"161","author":"Hussain","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.12968\/jowc.2018.27.12.843","article-title":"Investigation of galectin-3 levels in diabetic foot ulcers","volume":"27","author":"Gunes","year":"2018","journal-title":"J. Wound Care"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Caridi, B., Doncheva, D., Sivaprasad, S., and Turowski, P. (2021). Galectins in the Pathogenesis of Common Retinal Disease. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.687495"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dawi, J., Tumanyan, K., Tomas, K., Misakyan, Y., Gargaloyan, A., Gonzalez, E., Hammi, M., Tomas, S., and Venketaraman, V. (2025). Diabetic Foot Ulcers: Pathophysiology, Immune Dysregulation, and Emerging Therapeutic Strategies. Biomedicines, 13.","DOI":"10.3390\/biomedicines13051076"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lin, H., Yang, Y., Wang, X., Chung, M., Zhang, L., Cai, S., Pan, X., and Pan, Y. (2025). Targeting the AGEs-RAGE axis: Pathogenic mechanisms and therapeutic interventions in diabetic wound healing. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1667620"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hara, A., Niwa, M., Kanayama, T., Noguchi, K., Niwa, A., Matsuo, M., Kuroda, T., Hatano, Y., Okada, H., and Tomita, H. (2020). Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology. Biomolecules, 10.","DOI":"10.3390\/biom10091277"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ahmed, R., Anam, K., and Ahmed, H. (2023). Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098116"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9186940","DOI":"10.1155\/2018\/9186940","article-title":"The Role of Galectins as Modulators of Metabolism and Inflammation","volume":"2018","author":"Brinchmann","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mimura, S., Morishita, A., Oura, K., Takuma, K., Nakahara, M., Tadokoro, T., Fujita, K., Tani, J., and Kobara, H. (2025). Galectins and Liver Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020790"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1021\/acs.jmedchem.2c00660","article-title":"Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease","volume":"65","author":"Zetterberg","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00018-023-04768-x","article-title":"Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling","volume":"80","author":"Zukowska","year":"2023","journal-title":"Cell Mol. Life Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/med.22041","article-title":"Galectin-8 inhibition and functions in immune response and tumor biology","volume":"44","author":"Puric","year":"2024","journal-title":"Med. Res. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Stojanovic, B., Jovanovic, I., Dimitrijevic Stojanovic, M., Milosevic, B., Spasic, M., Stojanovic, B.S., Jakovljevic, S., Zornic, N., Jovanovic, D., and Nesic, J. (2025). Galectins as Master Regulators of Gastric Cancer Progression. Cells, 14.","DOI":"10.3390\/cells14141090"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00281-024-01010-z","article-title":"Intracellular galectin interactions in health and disease","volume":"46","author":"Jacob","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Boutin, L., Depret, F., Gayat, E., Legrand, M., and Chadjichristos, C.E. (2022). Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063124"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/WCO.0000000000000812","article-title":"Galectins in the brain: Advances in neuroinflammation, neuroprotection and therapeutic opportunities","volume":"33","author":"Barake","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lau, L.S., Mohammed, N.B.B., and Dimitroff, C.J. (2022). Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415554"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102622","DOI":"10.1016\/j.jbc.2022.102622","article-title":"Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases","volume":"298","author":"Hogan","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8696543","DOI":"10.1155\/2018\/8696543","article-title":"Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities","volume":"2018","author":"Seropian","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Petrovic, I., Pejnovic, N., Ljujic, B., Pavlovic, S., Miletic Kovacevic, M., Jeftic, I., Djukic, A., Draginic, N., Andjic, M., and Arsenijevic, N. (2020). Overexpression of Galectin 3 in Pancreatic beta Cells Amplifies beta-Cell Apoptosis and Islet Inflammation in Type-2 Diabetes in Mice. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00030"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cardenas-Leon, C.G., Maemets-Allas, K., Klaas, M., Lagus, H., Kankuri, E., and Jaks, V. (2022). Matricellular proteins in cutaneous wound healing. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1073320"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bertuzzi, S., Quintana, J.I., Arda, A., Gimeno, A., and Jimenez-Barbero, J. (2020). Targeting Galectins with Glycomimetics. Front. Chem., 8.","DOI":"10.3389\/fchem.2020.00593"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101271","DOI":"10.1016\/j.jbc.2021.101271","article-title":"Molecular dynamics simulations elucidate oligosaccharide recognition pathways by galectin-3 at atomic resolution","volume":"297","author":"Koneru","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Modenutti, C.P., Capurro, J.I.B., Di Lella, S., and Marti, M.A. (2019). The Structural Biology of Galectin-Ligand Recognition: Current Advances in Modeling Tools, Protein Engineering, and Inhibitor Design. Front. Chem., 7.","DOI":"10.3389\/fchem.2019.00823"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ayona, D., Fournier, P.E., Henrissat, B., and Desnues, B. (2020). Utilization of Galectins by Pathogens for Infection. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01877"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Puigdellivol, M., Allendorf, D.H., and Brown, G.C. (2020). Sialylation and Galectin-3 in Microglia-Mediated Neuroinflammation and Neurodegeneration. Front. Cell Neurosci., 14.","DOI":"10.3389\/fncel.2020.00162"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wu, S.C., Ho, A.D., Kamili, N.A., Wang, J., Murdock, K.L., Cummings, R.D., Arthur, C.M., and Stowell, S.R. (2021). Full-Length Galectin-3 Is Required for High Affinity Microbial Interactions and Antimicrobial Activity. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.731026"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"937","DOI":"10.4236\/ojog.2019.97091","article-title":"Clinical significance of serum galectin-1 and its tissue immunohistochemical expression in serous ovarian carcinoma patients","volume":"9","author":"Abdelwahab","year":"2019","journal-title":"Open J. Obstet. Gynecol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Seropian, I.M., Cassaglia, P., Miksztowicz, V., and Gonzalez, G.E. (2023). Unraveling the role of galectin-3 in cardiac pathology and physiology. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1304735"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41419-020-03367-z","article-title":"Galectin-1 accelerates high-fat diet-induced obesity by activation of peroxisome proliferator-activated receptor gamma (PPAR\u03b3) in mice","volume":"12","author":"Baek","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00125-021-05594-1","article-title":"The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: Evidence from cross-sectional, longitudinal and Mendelian randomisation analyses","volume":"65","author":"Drake","year":"2022","journal-title":"Diabetologia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41366-024-01543-1","article-title":"Metabolic profiling of galectin-1 and galectin-3: A cross-sectional, multi-omics, association study","volume":"48","author":"Fryk","year":"2024","journal-title":"Int. J. Obes."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1096\/fj.201800555RR","article-title":"Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes","volume":"33","author":"Mohan","year":"2019","journal-title":"FASEB J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41598-020-58132-1","article-title":"Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_58","first-page":"e1","article-title":"Galectin-1 studies in proliferative diabetic retinopathy","volume":"98","author":"Ahmad","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1179069519836794","DOI":"10.1177\/1179069519836794","article-title":"Galectins in the Pathogenesis of Cerebrovascular Accidents: An Overview","volume":"13","author":"Abel","year":"2019","journal-title":"J. Exp. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Negedu, M.N., Duckworth, C.A., and Yu, L.G. (2022). Galectin-2 in Health and Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010341"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.3390\/cimb45110554","article-title":"Galectin-10 Expression in Placentas of Women with Gestational Diabetes","volume":"45","author":"Buschmann","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Hepp, P., Unverdorben, L., Hutter, S., Kuhn, C., Ditsch, N., Gross, E., Mahner, S., Jeschke, U., Knabl, J., and Heidegger, H.H. (2020). Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072404"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5021\/ad.2018.30.3.375","article-title":"Decreased Galectin-3 and -7 Expressions in Old-Aged Skin and Their Differential Expression in Skin Equivalents","volume":"30","author":"Choi","year":"2018","journal-title":"Ann. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/1346-8138.16048","article-title":"Enhanced galectin-7 expression favors wound healing","volume":"48","author":"Pinto","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00109-022-02207-1","article-title":"Regulation of wound healing and fibrosis by galectins","volume":"100","author":"Yu","year":"2022","journal-title":"J. Mol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kaminker, J.D., and Timoshenko, A.V. (2021). Expression, Regulation, and Functions of the Galectin-16 Gene in Human Cells and Tissues. Biomolecules, 11.","DOI":"10.3390\/biom11121909"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Srejovic, I., Selakovic, D., Jovicic, N., Jakovljevic, V., Lukic, M.L., and Rosic, G. (2020). Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior. Biomolecules, 10.","DOI":"10.3390\/biom10050798"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kozak, K., and Zajkowska, M. (2025). Association of Elevated Galectin-4 Concentrations with Obesity, Diabetes, and Cardiovascular Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199402"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.4110\/in.2019.19.e17","article-title":"Galectin-4 Interaction with CD14 Triggers the Differentiation of Monocytes into Macrophage-like Cells via the MAPK Signaling Pathway","volume":"19","author":"Hong","year":"2019","journal-title":"Immune Netw."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BST20200677","article-title":"Galectin-8, cytokines, and the storm","volume":"50","author":"Zick","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1007\/s00018-018-2856-2","article-title":"Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3","volume":"75","author":"Weinmann","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Iwasaki-Hozumi, H., Chagan-Yasutan, H., Ashino, Y., and Hattori, T. (2021). Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases. Biomolecules, 11.","DOI":"10.3390\/biom11030430"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Tsao, C.H., Hsieh, W.C., Lin, F.J., Liu, F.T., and Yang, R.Y. (2025). Galectin-12 in the Regulation of Sebocyte Proliferation, Lipid Metabolism, and Immune Responses. Biomolecules, 15.","DOI":"10.3390\/biom15060837"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wan, L., Yang, R.Y., and Liu, F.T. (2018). Galectin-12 in Cellular Differentiation, Apoptosis and Polarization. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010176"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Lin, E.S., Hsu, Y.A., Chang, C.Y., Lin, H.J., Chen, C.S., and Wan, L. (2020). Ablation of Galectin-12 Inhibits Atherosclerosis through Enhancement of M2 Macrophage Polarization. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155511"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jid.2023.03.1684","article-title":"Galectin-12 Regulates Immune Responses in the Skin through Sebaceous Glands","volume":"143","author":"Lin","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3892\/mmr.2022.12682","article-title":"The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review)","volume":"25","author":"Englisz","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Jiang, Z., Zhang, W., Sha, G., Wang, D., and Tang, D. (2022). Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma. Cancers, 14.","DOI":"10.3390\/cancers14225475"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Morrison, H.M., Craft, J., Rivera-Lugo, R., Johnson, J.R., Golovkine, G.R., Bell, S.L., Dodd, C.E., Van Dis, E., Beatty, W.L., and Margolis, S.R. (2023). Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011088"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Diaz Del Arco, C., Estrada Munoz, L., Ceron Nieto, M.L.A., Molina Roldan, E., Fernandez Acenero, M.J., and Garcia Gomez de Las Heras, S. (2024). Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071508"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Geng, K., Ma, X., Jiang, Z., Huang, W., Gao, C., Pu, Y., Luo, L., Xu, Y., and Xu, Y. (2021). Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.653940"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"116577","DOI":"10.1016\/j.lfs.2019.116577","article-title":"Assessment of serum galectin-3, methylated arginine and Hs-CRP levels in type 2 diabetes and prediabetes","volume":"231","author":"Atalar","year":"2019","journal-title":"Life Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"20285","DOI":"10.1038\/s41598-023-47426-9","article-title":"Galectin-4 is associated with diabetes and obesity in a heart failure population","volume":"13","author":"Dieden","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Jujic, A., Vieira, J.P.P., Matuskova, H., Nilsson, P.M., Lindblad, U., Olsen, M.H., Duarte, J.M.N., Meissner, A., and Magnusson, M. (2023). Plasma Galectin-4 Levels Are Increased after Stroke in Mice and Humans. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202303.0373.v1"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41467-021-27801-8","article-title":"Single cell transcriptomic landscape of diabetic foot ulcers","volume":"13","author":"Theocharidis","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Pelech, A., Ruszala, M., Niebrzydowska-Tatus, M., Bien, K., Kimber-Trojnar, Z., Czuba, M., Swistowska, M., and Leszczynska-Gorzelak, B. (2023). Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study. Biomolecules, 13.","DOI":"10.3390\/biom13040697"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"18981","DOI":"10.1038\/s41598-025-03879-8","article-title":"Role of galectin-9 in the development of gestational diabetes mellitus","volume":"15","author":"Albuayjan","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Wang, L., Zhang, C., Ji, J., and Jiao, Q. (2025). Galectin-9: Diverse roles in skin disease. Front. Allergy, 6.","DOI":"10.3389\/falgy.2025.1614277"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lin, C.W., Hung, C.M., Chen, W.J., Chen, J.C., Huang, W.Y., Lu, C.S., Kuo, M.L., and Chen, S.G. (2022). New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102065"},{"key":"ref_90","first-page":"8952414","article-title":"Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus","volume":"2019","author":"Chen","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1038\/s41467-022-35334-x","article-title":"Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.molmed.2024.11.006","article-title":"Galectin-3 in metabolic disorders: Mechanisms and therapeutic potential","volume":"31","author":"Jiang","year":"2025","journal-title":"Trends Mol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Nikolova, D., and Kamenov, Z. (2025). New Markers for the Assessment of Microvascular Complications in Patients with Metabolic Syndrome. Metabolites, 15.","DOI":"10.3390\/metabo15030184"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.gendis.2022.05.020","article-title":"A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)","volume":"10","author":"Lv","year":"2023","journal-title":"Genes Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Fryk, E., Silva, V.R.R., and Jansson, P.A. (2022). Galectin-1 in Obesity and Type 2 Diabetes. Metabolites, 12.","DOI":"10.3390\/metabo12100930"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-041015-055402","article-title":"Galectins and Immune Responses\u2014Just How Do They Do Those Things They Do?","volume":"34","author":"Thiemann","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1038\/s41598-021-98227-x","article-title":"Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus","volume":"11","author":"Schmitt","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Aldahish, A., Shanmugasundaram, N., Vasudevan, R., Alqahtani, T., Alqahtani, S., Mohammad Asiri, A., Devanandan, P., Thamaraikani, T., Vellapandian, C., and Jayasankar, N. (2024). Silk Fibroin Nanofibers: Advancements in Bioactive Dressings through Electrospinning Technology for Diabetic Wound Healing. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101305"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"20070","DOI":"10.1038\/s41598-020-76952-z","article-title":"Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis","volume":"10","author":"Iacobini","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhang, W., Chen, L., Xiong, Y., Panayi, A.C., Abududilibaier, A., Hu, Y., Yu, C., Zhou, W., Sun, Y., and Liu, M. (2021). Antioxidant Therapy and Antioxidant-Related Bionanomaterials in Diabetic Wound Healing. Front. Bioeng. Biotechnol., 9.","DOI":"10.3389\/fbioe.2021.707479"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update","volume":"8","author":"Suthahar","year":"2018","journal-title":"Theranostics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"H364","DOI":"10.1152\/ajpheart.00523.2020","article-title":"Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt","volume":"320","author":"Sun","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"110071","DOI":"10.1016\/j.biopha.2020.110071","article-title":"Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4\/MyD88\/NF-kappaB signaling pathway","volume":"126","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/DMSO.S194410","article-title":"Galectin-3 as a prognostic biomarker for diabetic nephropathy","volume":"12","author":"Hodeib","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-015-0230-3","article-title":"Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes","volume":"14","author":"Darrow","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Nio-Kobayashi, J., and Itabashi, T. (2021). Galectins and Their Ligand Glycoconjugates in the Central Nervous System Under Physiological and Pathological Conditions. Front. Neuroanat., 15.","DOI":"10.3389\/fnana.2021.767330"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Sango, K., Yako, H., Niimi, N., and Takaku, S. (2024). Immortalized Schwann cell lines as useful tools for pathogenesis-based therapeutic approaches to diabetic peripheral neuropathy. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1531209"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2018.07.018","article-title":"Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice","volume":"1700","author":"Carvalho","year":"2018","journal-title":"Brain Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.4103\/1673-5374.391181","article-title":"Emerging role of galectin 3 in neuroinflammation and neurodegeneration","volume":"19","author":"Lozinski","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease","volume":"10","author":"Siew","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Golboyu, B.E., Erdogan, M.A., Cosar, M.A., Balikoglu, E., and Erbas, O. (2024). Diosmin and Hesperidin Have a Protective Effect in Diabetic Neuropathy via the FGF21 and Galectin-3 Pathway. Medicina, 60.","DOI":"10.3390\/medicina60101580"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s40200-024-01461-z","article-title":"A closer look at Galectin-3: Its association with gestational diabetes mellitus revealed by systematic review and meta-analysis","volume":"23","author":"Bahreiny","year":"2024","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"tkaf044","DOI":"10.1093\/burnst\/tkaf044","article-title":"O-linked beta-N-acetylglucosamine modification in diabetic foot ulcer pathogenesis","volume":"13","author":"Qi","year":"2025","journal-title":"Burns Trauma"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"95","DOI":"10.22270\/ajprd.v11i4.1293","article-title":"A Detailed Review on Diabetic Wound Healing Activity","volume":"11","author":"Bhopale","year":"2023","journal-title":"Asian J. Pharm. Res. Dev."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Petkovic, M., Sorensen, A.E., Leal, E.C., Carvalho, E., and Dalgaard, L.T. (2020). Mechanistic Actions of microRNAs in Diabetic Wound Healing. Cells, 9.","DOI":"10.3390\/cells9102228"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"200223","DOI":"10.1098\/rsob.200223","article-title":"Wound healing: Cellular mechanisms and pathological outcomes","volume":"10","author":"Wilkinson","year":"2020","journal-title":"Open Biol."},{"key":"ref_117","first-page":"27","article-title":"Galectin 1 in dermatology: Current knowledge and perspectives","volume":"28","author":"Pasmatzi","year":"2019","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/glycob\/cwab040","article-title":"Galectin-1 impacts on glucose homeostasis by modulating pancreatic insulin release","volume":"31","author":"Sundblad","year":"2021","journal-title":"Glycobiology"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Rehak, L., Giurato, L., Meloni, M., Panunzi, A., Manti, G.M., and Uccioli, L. (2022). The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration-A Narrative Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030889"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40659-024-00490-5","article-title":"Galectins in epithelial-mesenchymal transition: Roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis","volume":"57","author":"Oyanadel","year":"2024","journal-title":"Biol. Res."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Cardoso, A.C., Andrade, L.N., Bustos, S.O., and Chammas, R. (2016). Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments. Front. Oncol., 6.","DOI":"10.3389\/fonc.2016.00127"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Thijssen, V.L. (2021). Galectins in Endothelial Cell Biology and Angiogenesis: The Basics. Biomolecules, 11.","DOI":"10.3390\/biom11091386"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"McLeod, K.M., Gregerio, M.D., Tinney, D., Carmichael, J.J., Zuanazzi, D., Siqueira, W.L., Rizkalla, A., and Hamilton, D.W. (2024). Assessment of Wound Bed Delivery of Galectin-3 to Modulate Macrophage Polarization, Re-epithelialization and Collagen Synthesis in a Murine Model of Excisional Skin Healing. Preprint.","DOI":"10.20944\/preprints202408.1653.v1"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3892\/mmr.2020.11738","article-title":"Human galectin-3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions in vivo","volume":"23","author":"Gal","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"112713","DOI":"10.1016\/j.intimp.2024.112713","article-title":"Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions","volume":"139","author":"Mohsin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.118.035047","article-title":"IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction","volume":"138","author":"Shirakawa","year":"2018","journal-title":"Circulation"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Burgess, J.L., Wyant, W.A., Abdo Abujamra, B., Kirsner, R.S., and Jozic, I. (2021). Diabetic wound-healing science. Medicina, 57.","DOI":"10.3390\/medicina57101072"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/iwj.13103","article-title":"Characterisation of dehydrated amnion chorion membranes and evaluation of fibroblast and keratinocyte responses in vitro","volume":"16","author":"McQuilling","year":"2019","journal-title":"Int. Wound J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1884515","article-title":"Human galectin-1 and galectin-3 promote Tropheryma whipplei infection","volume":"13","author":"Ayona","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Lambris, J.D., and Hajishengallis, G. (2012). Current Topics in Innate Immunity II, Springer.","DOI":"10.1007\/978-1-4614-0106-3"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Iftimie, S., Hernandez-Aguilera, A., Lopez-Azcona, A.F., Castane, H., Rodriguez-Tomas, E., Baiges-Gaya, G., Camps, J., Castro, A., and Joven, J. (2022). Measurement of Plasma Galectin-3 Concentrations in Patients with Catheter Infections: A Post Hoc Retrospective Cohort Study. Diagnostics, 12.","DOI":"10.3390\/diagnostics12102418"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Velickovic, M., Arsenijevic, A., Acovic, A., Arsenijevic, D., Milovanovic, J., Dimitrijevic, J., Todorovic, Z., Milovanovic, M., Kanjevac, T., and Arsenijevic, N. (2021). Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.638258"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/ecco-jcc\/jjw013","article-title":"Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1beta in Macrophages","volume":"10","author":"Nikolic","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Sasaki, T., Oyama, M., Kubota, M., Isshiki, Y., Takeuchi, T., Tanaka, T., Tanikawa, T., Tamura, M., Arata, Y., and Hatanaka, T. (2024). Galectin-2 Agglutinates Helicobacter pylori via Lipopolysaccharide Containing H Type I Under Weakly Acidic Conditions. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168725"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"jcs208884","DOI":"10.1242\/jcs.208884","article-title":"Galectins at a glance","volume":"131","author":"Johannes","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2018.02.022","article-title":"Unconventional secretion of annexins and galectins","volume":"83","author":"Popa","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cell.2020.03.031","article-title":"A Translocation Pathway for Vesicle-Mediated Unconventional Protein Secretion","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4614-0106-3_2","article-title":"Galectins as pattern recognition receptors: Structure, function, and evolution","volume":"946","author":"Vasta","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1210\/jc.2019-00398","article-title":"Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study","volume":"104","author":"Vora","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.metabol.2016.04.003","article-title":"Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients","volume":"65","author":"Fryk","year":"2016","journal-title":"Metabolism"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Wang, F., Zhou, L., Eliaz, A., Hu, C., Qiang, X., Ke, L., Chertow, G., Eliaz, I., and Peng, Z. (2023). The potential roles of galectin-3 in AKI and CKD. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1090724"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Hsu, B.G., Wang, C.H., Lai, Y.H., and Tsai, J.P. (2021). Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5. Toxins, 13.","DOI":"10.3390\/toxins13080532"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Ou, S.M., Tsai, M.T., Chen, H.Y., Li, F.A., Lee, K.H., Tseng, W.C., Chang, F.P., Lin, Y.P., Yang, R.B., and Tarng, D.C. (2022). Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030585"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Leal-Perez, N., Blanco-Colio, L.M., Martin-Ventura, J.L., Gutierrez-Landaluce, C., Mahillo-Fernandez, I., Gonzalez-Casaus, M.L., Lorenzo, O., Egido, J., and Tunon, J. (2025). High Levels of Galectin-3 and Uric Acid Are Independent Predictors of Renal Impairment in Patients with Stable Coronary Artery Disease. J. Clin. Med., 14.","DOI":"10.3390\/jcm14155264"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Lorenzo-Almoros, A., Pello, A., Acena, A., Martinez-Milla, J., Gonzalez-Lorenzo, O., Tarin, N., Cristobal, C., Blanco-Colio, L.M., Martin-Ventura, J.L., and Huelmos, A. (2020). Galectin-3 Is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041105"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"873","DOI":"10.17219\/acem\/147665","article-title":"Impact of moderately reduced renal function on the diagnostic and prognostic value of galectin-3 in patients with exertional dyspnea","volume":"31","author":"Karolko","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2021.1903430","article-title":"An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016\u2013present)","volume":"31","author":"Sethi","year":"2021","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2002559","DOI":"10.1183\/13993003.02559-2020","article-title":"Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Hirani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/kjm2.12890","article-title":"In vitro and in vivo effects of Galectin-3 inhibitor TD139 on inflammation and ERK\/JNK\/p38 pathway in gestational diabetes mellitus","volume":"40","author":"Xia","year":"2024","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/JIR.S273858","article-title":"Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro","volume":"13","author":"Yin","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Karahan, B., Binici, D.N., Karasahin, O., Yilmaz, S.I., Kiziltunc, A., and Mercantepe, F. (2025). Serum sICAM-1 and Galectin-3 Levels in Diabetic Patients with COVID-19. Viruses, 17.","DOI":"10.3390\/v17071005"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Cassidy, B., Kendrick, C., Reeves, N.D., Pappachan, J.M., O\u2019Shea, C., Armstrong, D.G., and Yap, M.H. (2021). Diabetic foot ulcer grand challenge 2021: Evaluation and summary. Diabetic Foot Ulcers Grand Challenge, Springer.","DOI":"10.1007\/978-3-030-94907-5_7"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Compagno, D., Tiraboschi, C., Garcia, J.D., Rondon, Y., Corapi, E., Velazquez, C., and Laderach, D.J. (2020). Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials. Biomolecules, 10.","DOI":"10.3390\/biom10050750"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"SE211","DOI":"10.4052\/tigg.1744.1SE","article-title":"Clinical trials and applications of galectin antagonists","volume":"30","author":"Girard","year":"2018","journal-title":"Trends Glycosci. Glycotechnol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3892\/ijmm.2025.5567","article-title":"Cell migration in diabetic wound healing: Molecular mechanisms and therapeutic strategies (Review)","volume":"56","author":"Song","year":"2025","journal-title":"Int. J. Mol. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"20251137","DOI":"10.1515\/biol-2025-1137","article-title":"Understanding risk factors and prognosis in diabetic foot ulcers","volume":"20","author":"Wang","year":"2025","journal-title":"Open Life Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"20417314241253290","DOI":"10.1177\/20417314241253290","article-title":"Microenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics","volume":"15","author":"Zhao","year":"2024","journal-title":"J. Tissue Eng."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Zhou, X., Dai, N., Yu, D., Niu, T., and Wang, S. (2024). Exploring galectin-3\u2019s role in predicting mild cognitive impairment in type 2 diabetes and its regulation by miRNAs. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1443133"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Bogut, A., Stojanovic, B., Jovanovic, M., Dimitrijevic Stojanovic, M., Gajovic, N., Stojanovic, B.S., Balovic, G., Jovanovic, M., Lazovic, A., and Mirovic, M. (2023). Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115500"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Cui, J., Zhang, S., Cheng, S., and Shen, H. (2023). Current and future outlook of loaded components in hydrogel composites for the treatment of chronic diabetic ulcers. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1077490"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"113440","DOI":"10.1016\/j.isci.2025.113440","article-title":"Immune microenvironment and fibroblast subpopulation in diabetic wound healing","volume":"28","author":"Gan","year":"2025","journal-title":"iScience"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Dings, R.P.M., Miller, M.C., Griffin, R.J., and Mayo, K.H. (2018). Galectins as Molecular Targets for Therapeutic Intervention. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030905"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/232\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:28:39Z","timestamp":1770110919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":163,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["biom16020232"],"URL":"https:\/\/doi.org\/10.3390\/biom16020232","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}